Inherited disorders of platelet alpha-granules

References

• Harrison P, Savidge GF, C ram er EM. The origin and physio- logical relevance of a-granule adhesive proteins. Br J Haematol 1990; 74: 125– 30.
   PubMed Web of Science ®Google Scholar
• Harrison P, Cram er EM. Platelet a-granules. Blood Rev 1993; 7: 52– 62.
   PubMed Web of Science ®Google Scholar
• Cramer EM, M eyer D, le Menn R, B reton Gorius J. Eccentric localization of von Willebrand factor in an internal structure of platelet a-granule resem bling that of Weibel– Palade bodies. Blood 1985; 66: 710– 3.
   PubMed Web of Science ®Google Scholar
• Cramer EM, Caen JP, Drouet L, Breton-Gorius J. Absence of tubular structures and immunolabeling for von Willebrand factor in the platelet a-granules from porcine von Willebrand disease. Blood 1986; 68: 774– 8.
   Google Scholar
• Cramer E M, Beesley J, Breton-Gorius J, Martin JF. Ulstr- structural dem onstration of tubular inclusions coinciding with von Willebrand factor in pig m egakaryocytes. Blood 1988; 71: 1533– 8.
   Google Scholar
• Wilbourn B, Harrison P, L awrie A, Savariau E, Savidge G, Cram er E M. Porcine platelets contain an increased quantity of ultra-high m olecular weight von Willebrand factor and num erous alpha-granular tubular structures. Br J Haematol 1993; 83: 608–15.
   Google Scholar
• Roussi J, Drouet L, Sigm an J, Vaim an M, Pignaud G, Bonneau M, Masse J-M, Cramer EM. Absence of incorporation of plasm a von Willebrand factor into porcine platelet a-granules. B r J Haematol 1995; 90: 661± 8.
   Google Scholar
• Hayward CPM, Bainton DF, Smith JW, Horsewo od P, Stead RH, Podor TJ, Warkentin T E, Kelton JG. Multim erin is found in the a-granules of resting platelets and is synthesized by a mega- karyocytic cell line. J Clin Invest 1993; 91: 2630– 9.
   PubMedGoogle Scholar
• Hayward CPM, Furmaniak-Kazm ierczak E, Cieutat A-M, Moore JC, Bainton DF, Nesheim M E, Kelton JG, Coà t… G. Factor V is com plexed with m ultim erin in resting platelet lysates and colocalizes with m ultim erin in platelet a-granules. J Biol Chem 1995; 270: 19217± 24.
   PubMedGoogle Scholar
• Hsu-Lin S, Berman CL, Furie BC, August D, Furie B. A platelet m embrane protein expressed during platelet activation and secretion. J Biol Chem 1984; 259: 9121± 6.
   PubMed Web of Science ®Google Scholar
• McEver RP, Martin MN. Am onoclonal antibody to a m embrane glycoprotein binds only to activated platelets. J B iol Chem 1984; 259: 9799– 804.
   PubMed Web of Science ®Google Scholar
• Stenberg PE, M cEver R P, Shum an M A, Jacques YV, Bainton DF. A platelet alpha-granule m embrane protein (GMP-14 0) is expressed on the plasma m embrane after activation. J Cell Biol 1985; 101: 880– 6.
   PubMed Web of Science ®Google Scholar
• Berger G, M asse J-M, Cramer EM. Alpha-granule m embrane m irrors the platelet plasm a m embrane and contains glycoproteins Ib, IX and V. B lood 1996; 87: 1385– 95.
   Google Scholar
• Cramer EM, Savidge GF, Vainchenker W, Berndt MC, Pidard D, Caen JP, M asse J-M, Breton-Borius J. Alpha-granule pool of glycoprotein IIb– IIIa in norm al and pathologic platelets and m egakaryocytes. Blood 1990; 75: 1220–7.
   PubMed Web of Science ®Google Scholar
• Raccuglia G. Gray platelet syndrom e. A variety of qualitative platelet disorder. A m J M ed 1971; 51: 818– 28.
   PubMed Web of Science ®Google Scholar
• White JG. Ultrastructural studies of the gray platelet syndrome. Am J Pathol 1979; 95: 445– 53.
   PubMed Web of Science ®Google Scholar
• Gerrard JM, Phillips DR, Rao GHR, Plow EF, Walz DA, Ross R, Harker L A, W hite JG. Biochem ical studies of two patients with the gray platelet syndrome. Selective deficiency of platelet alpha granules. J C lin Invest 1980; 66: 102– 9.
   PubMed Web of Science ®Google Scholar
• Levy-Toledano S, Caen JP, B reton-Gorius J, Rendu F, Cywiner- Golenzer C, Dupuy E, Legrand Y, M aclouf J. Gray platelet syndrom e: a-granule deficiency. Its influence on platelet func- tion. J Lab Clin Med 1981; 98: 831± 48.
   PubMedGoogle Scholar
• Breton-Gorius J, Vainchenker W, Nurden A, L evy-Toledano S, Caen J. Defective alpha-granule production in m egakaryocytes from gray platelet syndrom e: Ultrastructural studies of bone m arrow cells and m egakaryocytes growing in culture of blood precursors. Am J Pathol 1981; 102: 10–19.
   PubMed Web of Science ®Google Scholar
• Nurden AT, Kunicki TJ, Dupuis D, Soria C, Caen JP. Specific protein and glycoprotein deficiencies in platelets isolated from two patients with the gray platelet syndrom e. Blood 1982; 59: 709–18.
   Google Scholar
• Berndt MC, C astaldi PA, G ordon S, Halley H, McPherson VJ. M orphological and biochem ical confirm ation of gray platelet syndrom e in tw o siblings. A ust N Z J M ed 1983; 13: 387± 90.
   PubMedGoogle Scholar
• J. Cramer E M, Vainchecker W, Vinci G, Guichard J, Breton-Gorius Gray platelet syndrome: Im m unoelectron m icroscopic local- ization of fibrinogen and von Willebrand factor in platelets and m egakaryocytes. Blood 1985; 66: 1309–16.
   PubMed Web of Science ®Google Scholar
• Mori K, Suzuki S, Sugai K. Electron m icroscopic and functional studies on platelets in gray platelet syndrome. Tohoku J Exp Med 1984; 143: 261± 87.
   PubMed Web of Science ®Google Scholar
• Köhler M, Hellstern P, M orgenstern E, Mueller-Eckhardt C, Berberich R, M eiser RJ, Scheffler P, Wenzel E. Gray platelet syndrom e: selective a-granule deficiency and throm bocytopenia due to increased platelet turnover. Blut 1985; 50: 331± 40.
   PubMedGoogle Scholar
• Greenberg-Sepersky SM, Sim ons ER, W hite JG. Studies of platelets from patients with the gray platelet syndrome. Br J Haematol 1985; 59: 603– 9.
   Google Scholar
• Rosa J-P, George JN, Bainton DF, Nurden AT, Caen JP, M cEver RP. Gray platelet syndrome. Dem onstration of alpha granule m embranes that can fuse with the cell surface. J C lin Invest 1987; 80: 1138– 46.
   PubMed Web of Science ®Google Scholar
• Studies on granule-bound substances in 18 patients including variants deficient in a-granules, platelet factor 4, b-throm boglo- bulin and platelet-derived growth factor. B lood 1979; 54: 1296– 319.
   Google Scholar
• Weiss HJ, Chervenick PA, Zalusky R, Factor A. A fam ilial defect in platelet function associated with impaired release of adenine diphosphate. New Engl J M ed 1969; 281: 1264–70.
   PubMed Web of Science ®Google Scholar
• Weiss HJ, Lages B, Vicic W, Tsung LY, W hite JG. Heterogeneous abnormalities of platelet dense granule ultrastucture in 20 patients with congenital storage pool deficiency. B r J Haematol 1993; 83: 282– 95.
   PubMed Web of Science ®Google Scholar
• Hayward CPM, Rivard GE, Kane W H, Drouin J, Z heng S, Moore JC, Kelton JG. An autosom al dom inant, qualitative platelet disorder associated with m ultim erin deficiency, abnorm alities in platelet factor V, throm bospondin, von Willebrand factor, and fibrinogen, and an epinephrine aggregation defect. B lood 1996; 87: 4967±78.
   Google Scholar
• Hayward CPM, Cram er EM, Kane W H, Zheng S, Bouchard M, Mass… J-M, Rivard GE. Studies of a second fam ily with the Quebec platelet disorder: evidence that the degradation of the a-granule mem brane and its soluble contents are not secondary to a defect in targeting proteins to a-granules. Blood 1997; 88: 1243– 53.
   Google Scholar
• Tracy PB, Giles AR, M ann KG, Eide LL, Hoogendoorn H, Rivard GE. Factor V (Quebec): a bleeding diathesis associated with a qualitative platelet factor V deficiency. J Clin Invest 1984; 74: 1221± 8.
   PubMed Web of Science ®Google Scholar
• Janeway C, R ivard GE, Tracy PB, Mann KG. Factor V Quebec revisited. Blood 1996; 87: 3571± 8.
   PubMed Web of Science ®Google Scholar
• Breton-Gorius J, Favier R, Guichard J, Cherif D, B erger R, Debili N, Vainchenker W, Douay L. A new congenital dysm egakar- yopoietic throm bocytopenia (Paris-Trousseau) associated with giant platelet a-granules and chrom osom e 11 deletion at 11q23. Blood 1995; 85: 1805–14.
   PubMed Web of Science ®Google Scholar
• Gangarossa S, Schiliró G, M attina T, Scardilli S, Mollica F, Cavallari V. Dysm egakeryopoietic thrombocytopenia in patients with distal chrom osom e 11q deletion. Blood 1996; 87: 4915– 6.
   Google Scholar
• Kane W H, Davie E W. Blood coagulation factor V and VIII: structural and functional sim ilarities and their relationship to hem orrhagic and thrombotic disorders. B lood 1988; 71: 539– 55.
   Google Scholar
• Miletich JP, Majerus DW, Majerus PW. Patients with congenital Factor V deficiency have decreased Factor Xa binding sites on their platelets. J C lin Invest 1978; 62: 824– 31.
   PubMed Web of Science ®Google Scholar
• Soria J, Soria C, Borg JY, M irshahi M, Piguet H, Tron P, Fessard C, Caen JP. Platelet aggregation occurs in congenital afi- brinogenemia despite the absence of fibrinogen of its fragm ents in plasm a and platelets, as dem onstrated by imm unoenzym ology. Br J Haematol 1985; 60: 503–14.
   PubMed Web of Science ®Google Scholar
• Cattaneo M, Kinlough-Rathbone RL, Lecchi A, Bevilacqua C, Packham M A, M ustard JF. Fibrinogen independent aggregation and disaggregation of hum an platelets: studies in two afi- brinogenemic patients. Blood 1987; 70: 221± 6.
   PubMedGoogle Scholar
• Rachman RL, Marcus AJ. Im m unological studies of proteins associated with subcellular fractions of throm basthenic and afibrinogenemic platelets. B r J Haematol 1968; 15: 181± 9.
   Google Scholar
• Al-Mondhiry H, Ehm ann W C. Congenital afibrinogenem ia. Am J Hematol 1994; 46: 343–7.
   PubMed Web of Science ®Google Scholar
• Disdier M, Legrand C, Bouillot C, Duberhard V, Pidard D, Nurden AT. Quantitation of platelet Fg and throm bospondin in Glanzm ann’s throm basthenia by electroimm unoassay. Thromb Res 1989; 53: 521± 33.
   Google Scholar
• Belloc F, Heilm ann E, Com brie R, Boisseau M R, Nurden AT. Protein synthesis and storage of fibrinogen in Glanzm ann’s throm basthenia. Biochem Biophys A cta 1987; 925: 218– 25.
   PubMed Web of Science ®Google Scholar
• Weiss HJ, Pietu G, Rabinowitz R, Girm a J-P, Rogers J, Meyer D. Heterogeneous abnorm alities in the m ultimeric structure, anti- genic properties, and plasm a-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand’s disease. J Lab Clin Med 1983; 101: 411± 25.
   PubMed Web of Science ®Google Scholar
• Mannucci PM, Lombardi R, Bader R, Vianello L, Federici AB, Solinas S, Mazzucconi M G, M ariani G. Heterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor. B lood 1985; 66: 796– 802.
   Google Scholar
• Gralnick HR, Rick ME, M cKeown LP, Williams SB, Parker RI, Maisonneuve P, Jeanneau C, Sultan Y. Platelet von Willebrand factor: an important determ inant of the bleeding tim e in type I von Willebrand’s disease. B lood 1986; 68: 58– 61.
   Google Scholar
• Wilbourn B, Harrison P, L awrie A, Savariau E, Savidge G, Cram er E M. Porcine platelets contain an increased quantity of ultra-high m olecular weight von Willebrand factor and num erous alpha-granular tubular structures. Br J Haematol 1993; 83: 608–15.
   Google Scholar
• Roussi J, Drouet L, Vaim an M, Pignaud G, Bonneau M, Masse J-M, Cram er EM. Absence of incorporation of plasm a von Willebrand factor into porcine platelet a-granules. B r J Haematol 1995; 90: 661± 8.
   Google Scholar
• Fay W P, Shapiro AD, Shih JL, Schleef RR, Ginsberg D. Brief report: complete deficiency of plasm inogen-activator inhibitor type 1 due to a frame-shift m utation. New Engl J Med 1992; 327: 1729– 33.
   Google Scholar
• Jantunen E, Hänninen A, Naukkarinen A, Vornanen M, Lahtinen R. Gray platelet syndrom e with splenom egaly and signs of extram edullary hem atopoiesis: a case report with review of the literature. A m J Hematol 1994; 46: 218– 24.
   Google Scholar
• Caen JP, Descham ps JF, Bodevin E, Bryckaert M C, Dupuy E, Wasteson A. M egakaryocytes and myelofibrosis in gray platelet syndrom e. Nouv Rev Fr Haematol 1987; 29: 109–14.
   PubMedGoogle Scholar
• Gootenberg JE, Buchanan GR, Holtkam p CA, Casey CS. Severe hem orrhage in a patient with gray platelet syndrom e. J P ediatrics 1986; 109: 1017± 9.
   Google Scholar
• Berrebi A, Klepfish A, Varon D, Shtalrid M, Vorst E, Nir E, Lavac Gray platelet syndrome in the elderly. Am J Hematol 1988; 28: 270– 2.
   Google Scholar
• Facon T, Goudemand J, Caron C, Zandecki M, Estienne M-H, Fenaux P, Cosson A. Sim ultaneous occurrence of grey platelet syndrom e and idiopathic pulmonary fibrosis: a role for abnorm al m egakaryocytes in the pathogenesis of pulm onary fibrosis? B r J Haematol 1990; 74: 542– 3.
   PubMed Web of Science ®Google Scholar
• Pfueller SL, Howard M A, W hite JG, Menon C, Berry E W. Shortening of the bleeding tim e by 1-deam ino-8-arginine vaso- pressin (DDAVP) in the absence of platelet von Willebrand factor in gray platelet syndrom e. Thromb Haemost 1987; 58: 1060– 3.
   PubMed Web of Science ®Google Scholar
• Köhler M. Treatm ent of gray platelet syndrom e. Thromb Haemost 1988; 60: 123.
   Google Scholar
• Cockbill SR, Burm ester HBC, Heptinstall S. Pseudo grey platelet syndrom e Ð grey platelets due to degranulation in blood collected into EDTA. Eur J Haematol 1988; 41: 326– 33.
   Google Scholar
• Srivastava PC, Powling MJ, Nokes TJ, Patrick AD, Dawes J, Hardisty RM. Grey platelet syndrome: studies on platelet alpha- granules, lysosom es and defective response to thrombin. B r J Haematol 1987; 65: 441± 6.
   PubMed Web of Science ®Google Scholar
• Lages B, Sussmann II, Levine SP, Coletti D, Weiss HJ. Platelet alpha granule deficiency associated with decreased P-selectin and selective impairm ent of throm bin-induced activation in a new patient with gray platelet syndrom e (a-storage pool deficiency). J Lab Clin Med 1997; 129: 364–75.
   PubMed Web of Science ®Google Scholar
• Enouf J, Lebret M, Bredoux R, Levy-Toledano S, Caen JP. Abnorm al calcium transport into m icrosom es of grey platelet syndrom e. Br J Haematol 1987; 65: 437± 50.
   PubMedGoogle Scholar
• Morgenstern E, Patscheke H, M athieu G. The origin of the m embrane convolute in degranulating platelets. A com parative study of norm al and `gray’ platelets. B lut 1990; 60: 15– 22.
   Google Scholar
• Baruch D, Lindhout T, Dupuy E, Caen J-P. Throm bin-induced platelet factor Va form ation in patients with a gray platelet syndrom e. Thromb Haemostas 1987; 58: 768–71.
   PubMedGoogle Scholar
• Vermylen C, Vermylen J, Hoet B, Scheiff JM, Ninane J, Cornu G. Grey platelet syndrome: evidence for alpha-granule localization of the platelet plasm inogen activator inhibitor-1 pool. Pediatr Hematol Oncol 1991; 8: 111± 20.
   PubMed Web of Science ®Google Scholar
• Pfueller SL, David R. Platelet-associated imm unoglobulins G, A, and M are secreted during platelet activation: normal levels but defective secretion in grey platelet syndrome. Br J Haematol 1988; 68: 235– 41.
   Google Scholar
• Boukerche H, Ruchaud-Spragano M -H, Rouen C, Brochier J, Kaplan C, McGregor JL. A m onoclonal antibody directed against a granule m embrane glycoprotein (GMP-14 0/PADGE M, P-se- lectin, CD62P) inhibits ristocetin-induced platelet aggregation. B r J Haematol 1996; 92: 44– 51.
   Google Scholar
• Mazurov AV, Vinogradov DV, Khaspekova SG, Krushinsky AV, Gerdeva LV, Vasiliev SA. Deficiency of P-selectin in a patient with grey platelet syndrom e. Eur J Haematol 1996; 57: 38– 41.
   Google Scholar
• Gebrane-Youn†s, Cramer EM, Orcel L, Caen JP. Gray platelet syndrom e. Dissociation between abnorm al sorting in mega- karyocyte a-granules and norm al sorting in Weibel– Palade bodies of endothelial cells. J Clin Invest 1993; 92: 3023– 8.
   Google Scholar
• Jackson CW, Hutson NK, Steward SA, Saito N, C ram er EM. Platelets of the Wistar Furth rat have reduced levels of alpha- granule proteins. An anim al model resem bling gray platelet syndrom e. J Clin Invest 1991; 87: 1985– 91.
   Google Scholar
• Pestina T I, Jackson CW, Stenberg PE. Abnorm al subcellular distribution of m yosin and talin in Wistar Furth rat platelets. Blood 1995; 85: 2436– 46.
   Google Scholar
• Lages B, Shattil S, Bainton DF, Weiss HJ. Decreased content and surface expression of alpha-granule m embrane protein GMP-140 in one of two types of platelet ad storage pool deficiency. J C lin Invest 1991; 87: 919– 29.
   PubMed Web of Science ®Google Scholar
• Weiss HJ, L ages B. Studies of throm boxane B 2, platelet factor 4, and fibrinopeptide A in bleeding tim e blood of patients deficient in von Willebrand factor, platelet glycoproteins Ib, IIb– IIIa, and storage granules. Blood 1993; 82: 481± 90.
   Google Scholar
• Weiss HJ, Lages B. The response of platelets to epinephrine in storage pool deficiency Ð evidence pertaining to the role of AD P in mediating prim ary and secondary aggregation. Blood 1988; 72: 1717± 25.
   PubMed Web of Science ®Google Scholar
• Weiss HJ, Lages B. Platelet m alondialdehyde production and aggregation responses induced by arachidonate, prostaglandin- G2, collagen, and epinephrine in 12 patients with storage pool deficiency. B lood 1981; 58: 27± 33.
   Google Scholar
• Weiss HJ, Turitto VT, Baumgartner HR. Platelet adhesion and throm bus form ation on subendothelium in platelets deficient in glycoproteins IIb– IIIa, Ib, and storage granules. Blood 1986; 67: 322– 30.
   PubMed Web of Science ®Google Scholar
• White JG. Inherited abnorm alities of the platelet m embrane and secretory granules. Hum Pathol 1987; 18: 123– 39.
   PubMedGoogle Scholar
• Vicic W J, Weiss HJ. Evidence that platelet a-granules are a m ajor determ inant of platelet density: studies in storage pool deficiency. Thromb Haemostas 1983; 50: 878– 80.
   Google Scholar
• Lages B, Dangelm aier C A, Holm sen H, Weiss HJ. Specific correction of impaired acid hydrolase secretion in storage pool- deficient platelets by adenosine diphosphate. J Clin Invest 1988; 81: 1865–72.
   Google Scholar
• Weiss HJ, Lages B. Platelet prothrom binase activity and intra- cellular calcium responses in platelets with glycoprotein IIb– IIIa deficiency, granule defects, or impaired platelet procoagulant activity Ð a com parison with Scott syndrom e. B lood 1997; 89: 1599– 611.
   Google Scholar
• Swank RT, Jiang SY, Reddington M, Conway J, Stephenson D, McGarry M P, Novak EK. Inherited abnorm alities in platelet organelles and platelet form ation and associated altered expres- sion of low m olecular weight guanosine triphosphate-binding proteins in the m ouse pigm ent mutant gunm etal. B lood 1993; 81: 2626– 35.
   Google Scholar
• Novak EK, Reddington M, Zhen L, Stenberg PE, Jackson CW, McGarry M P, Swank RT. Inherited throm bocytopenia caused by reduced platelet production in m ice with the gunm etal pigm ent gene mutation. Blood 1995; 85: 1781± 9.
   PubMed Web of Science ®Google Scholar
• Hayward CPM. Multim erin: a unique platelet and endothelial cell protein. From discovery to function to abnorm alities in disease. A bench to bedside chronology. Clin Invest M ed 1997; 20: 176– 87.
   PubMedGoogle Scholar
• Hayward CPM, Smith JW, Horsewood P, Warkentin TE, Kelton JG. p-155, a m ultim eric platelet protein that is expressed on activated platelets. J B iol Chem 1991; 266: 7114– 20.
   PubMedGoogle Scholar
• Hayward CPM, Warkentin T E, Horsewo od P, Kelton JG. Multim erin: a series of large, disulfide-linked m ultim eric proteins within platelets. Blood 1991; 77: 2556– 60.
   PubMedGoogle Scholar
• Hayward C PM, Hassell JA, Denom m e GA, Rachubinski RA, Brown C, Kelton JG. The cDNA sequence of hum an endothelial cell m ultim erin: A unique protein with RGDS, coiled-coil, and EGF-like dom ains and a carboxyl-terminus sim ilar to the globular dom ain of com plement C1q and collagens type VIII and X. J Biol Chem 1995; 270: 18242– 51.
   Google Scholar
• Hayward CPM, Welch B, Bouchard M, Zheng S, R ivard GE. Fibrinogen degradation products in patients with the Quebec platelet disorder. Br J Haematol 1977; 97: 497± 503.
   Google Scholar
• Gangarossa S, M attina T, Rom ano V, M ilana G, M ollica F, Schiliró G. Micromegakaryocytes in a patient with partial deletion of the long arm of chrom osom e 11 {del(11)q24.2qter)} and chronic throm bocytopenic purpura. Am J M ed Genet 1996; 62: 120– 3.
   Google Scholar
• Penny LA, Dell’Aquila M, Jones M C, Bergoffen J, Cunniff C, Fryns J-P, Grace E, Graham JM Jr, Kouseff B, Mattina T, Sym e J, Voullaire L, Zelante L, Zenger L, Z enger Haim J, Jones OW, Evans GA. Clinical and m olecular characterization of patients with distal 11q deletions. Am J Hum Genet 1995; 56: 676– 83.
   PubMedGoogle Scholar
• Bowie E J, Solberg LA Jr, Fass DN, Johnson CM, Stewart M L, Zoecklein LJ. Transplantation of norm al bone m arrow into a pig with severe vW d. J Clin Invest 1986; 78: 26– 30.
   Google Scholar
• Federici AB, DeGroot PG, Moia M, Ijsseldijk MJW, Sixm a JJ, Mannucci PM. Type I von Willebrand disease, subtype `platelet low’: decreased platelet adhesion can be explained by low synthesis of von Willebrand factor in endothelial cells. B r J Haematol 1993; 83: 88– 93.
   PubMed Web of Science ®Google Scholar
• Ewenstein BM, Inbal A, Pober JS, Handin RI. Molecular studies of von Willebrand disease: reduced von Willebrand factor biosynthesis, storage and release in endothelial cells derived from patients with type I von Willebrand disease. Blood 1990; 75: 1466–72.
   Google Scholar
• Roussi J, Drouet L, Sigm an J, Vaim an M, Pignaud G, Bonneau M, Masse J-M, Cramer EM. Absence of incorporation of plasm a von Willebrand factor into porcine platelet a-granules. B r J Haemat 1995; 90: 661± 8.
   Google Scholar
• Mannucci PM. Platelet von Willebrand factor in inherited and acquired bleeding disorders. Proc Natl Acad Sci 1995; 92: 2428– 32.
   PubMed Web of Science ®Google Scholar
• Nichols T C, Sam ama CM, Bellinger DA, Roussi J, Reddick R L, Bonneau M, Read M S, Bailliart O, Koch GG, Vaim an M, Sigm an JL, Pignaud GA, Brinkhous KM, Griggs T R, Drouet L. Function of von Willebrand factor after crossed bone m arrow transplantation between norm al and von Willebrand disease pigs: effect on arterial throm bosis in chimeras. P roc Natl Acad Sci 1995; 92: 2455– 9.
   Google Scholar
• Chediak J, Ashenhurst JB, Garlick I, Desser RK. Successful m anagem ent of bleeding in a patient with factor V inhibitor by platelet transfusions. B lood 1980; 56: 835– 41.
   Google Scholar
• Borchgrevink CF, Owren PA. The hem ostatic effect of normal platelets in hemophilia and factor V deficiency. T he importance of clotting factors adsorbed on platelets for norm al hem ostasis. Acta Med Scand 1961; 170: 375– 83.
   Google Scholar
• Nesheim M E, Nichols W L, Cole W L, C ole T L, Houston JG, Schenk RB, M ann KG, Bowie E JW. Isolation and study of an acquired inhibitor of hum an coagulation factor V. J Clin Invest 1986; 77: 405–15.
   Google Scholar
• Harrison P, Wilbourn B, Cram er E, Faint R, Mackie JJ, Bhattacharya S, Lahiri A, Tenza D, M achin SJ, Savidge SG. The influence of therapeutic blocking of GP IIb/IIIa on platelet a-granular fibrinogen. B r J Haematol 1992; 82: 721± 8.
   Google Scholar
• Harrison P, Wilbourn BR, Debili N, Vainchecker W, Breton- Gorius J, L awrie AS, M asse J-M, Savidge GF, Cram er EM. Uptake of plasm a fibrinogen into the a-granules of hum an m egakaryocytes and platelets. J Clin Invest 1989; 84: 1320– 4.
   PubMed Web of Science ®Google Scholar
• Fressinaud E, Federici AB, Castam an G, R othschild C, Rode- ghiero F, Baum gartner HR, Mannucci PM, Meyer D. T he role of platelet von Willebrand factor in platelet adhesion and throm bus formation: a study of 34 patients with various subtypes of type I von Willebrand disease. B r J Haematol 1994; 86: 327± 32.
   Google Scholar
• Castillo R, Escolar G, Monteagudo Y, Ordinas A, Garrido M, Moia M, Federici AB, Mannucci PM. Role for platelet von Willebrand factor in supporting platelet-vessel wall interactions in von Willebrand disease. Am J Hematol 1989; 31: 153– 8.
   Google Scholar
• D’Alessio P, Z waginga JJ, deB oer HC, Federici AB, Rodeghiero F, Castaman G, Mariani G, Mannucci PM, deGroot PG, Sixm a JJ. Platelet adhesion to collagen in subtypes of type I von Willebrand’s disease is dependent on platelet von Willebrand factor. Thromb Haemost 1990; 64: 227± 31.
   PubMed Web of Science ®Google Scholar
• Fressinaud E, Baruch D, Rothschild C, Baum gartner HS, Meyer D. Platelet von Willebrand factor: evidence for its involvem ent in platelet adhesion to collagen. Blood 1987; 70: 1214–7.
   PubMed Web of Science ®Google Scholar
• Lattuada A, Varanukulsak P, Castam an GC, Mannucci PM. The response of plasma von Willebrand factor to desm opressin (DDAVP) is related to the platelet levels of von Willebrand factor. Thromb Res 1992; 67: 467±71.
   Google Scholar
• Eller T, Brauer P, Albert J, Mayer J, Keller F. Significance and quantitative analysis of von Willebrand factor in hum an platelets. Thromb Res 1992; 65: 631± 40.
   Google Scholar
• Gralnick HR, Rick ME, M cKeown LP, Williams SB, Parker RI, Maisonneuve P, Jenneau C, Sultan Y. Platelet von Willebrand factor: an important determ inant of the bleeding tim e in type I von Willebrand’s disease. B lood 1986; 68: 58– 61.
   Google Scholar
• McKeown LP, William s SB, Shafer B, Murray N, Gralnick HR. Alpha granule proteins in type I von Willebrand’s disease. Am J Hematol 1993; 42: 158– 61.
   Google Scholar